CryoPort, Inc. Completes Development of CryoPort Express One-Way Shipper

BREA, Calif., Jan. 8, 2007 (PRIME NEWSWIRE) -- CryoPort, Inc. (Pink Sheets:CYRX) announced today that the Company has completed the final development phase of the five liter configuration of the CryoPort Express(r) One-Way Shipper System. Pre-launch pilot programs will be initiated with select biopharmaceutical companies and stem cell research providers to confirm the system's application in the safe, cost-effective, transportation of high value, temperature sensitive biomaterials in the global marketplace.

CryoPort's CEO Peter Berry commented on the recent developments, "Biotechnology companies involved in shipping expensive medicines in global supply chains have increased concerns about specimen security when low temperatures requiring multiple touches are involved, particularly with clinical trials conducted outside of the United States. As validation of our value proposition to reduce shipment risks, we have been contacted, on an unsolicited basis, by companies who are interested in getting involved as early adopters of the CryoPort Express(r) One-Way Shipper System."

Over the next several quarters, CryoPort expects to roll out the full product line of the CryoPort Express(r) Shipper System utilizing multiple sizes and configurations. The Company will keep the public and its shareholders abreast of the progression of the program as developments occur.

About CryoPort, Inc.

CryoPort ( develops leading edge, proprietary, technology driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical sectors. The products developed by CryoPort are essential components of the infrastructure required for the testing, research and end user delivery components that make up the foundation of the biopharmaceutical and biotechnology industries.

The Market News First logo is available at


This press release contains forward-looking statements. The words "estimate", "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

CONTACT:  First Capital Investors, Inc.
          Investor Relations:

          Vince Duhon

Stay up to date with MN1 NewsWire "NEWS YOU CAN TRUST" at